VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

Pasteurella multocida aroA mutant vaccine
Vaccine Information
  • Vaccine Name: Pasteurella multocida aroA mutant vaccine
  • Target Pathogen: Pasteurella multocida
  • Target Disease: Pasteurellosis, fowl cholera
  • Vaccine Ontology ID: VO_0002862
  • Type: Live, attenuated vaccine
  • Status: Research
  • Host Species as Laboratory Animal Model: Cow
  • aroA gene engineering:
    • Type: Gene mutation
    • Description: This aroA mutant is from Pasteurella multocida (Dagleish et al., 2007).
    • Detailed Gene Information: Click Here.
  • Immunization Route: Intramuscular injection (i.m.)
Host Response

Cattle Response

  • Persistence: An aroA mutant is highly attenuated in calves (Dagleish et al., 2007).
  • Efficacy: An aroA mutant induces significant protection in calves from challenge with wild type Pasteurella multocida (Dagleish et al., 2007).
  • Host IgG response
    • Description: After second vaccination, serum IgG titers rose. Groups receiving 10^9 and 10^8 CFU of the mutant had significantly higher titer of IgG than those receiving 10^7 CFU, and all vaccinated groups had significantly higher titers than the unvaccinated challenge control group of calves (Dagleish et al., 2007).
    • Detailed Gene Information: Click Here.
  • Host IgM response
    • Description: After the second vaccination, serum IgM titers rose. Groups receiving 10^9 and 10^8 CFU of the mutant had significantly higher titer of IgM than those receiving 10^7 CFU, and all vaccinated groups had significantly higher titers than the unvaccinated challenge control group of calves (Dagleish et al., 2007).
    • Detailed Gene Information: Click Here.
References
Dagleish et al., 2007: Dagleish MP, Hodgson JC, Ataei S, Finucane A, Finlayson J, Sales J, Parton R, Coote JG. Safety and protective efficacy of intramuscular vaccination with a live aroA derivative of Pasteurella multocida B:2 against experimental hemorrhagic septicemia in calves. Infection and immunity. 2007; 75(12); 5837-5844. [PubMed: 17875632].